Table 2.
All | RBP Low | RBP High | P Value | |
---|---|---|---|---|
No. | 372 | 321 | 51 | |
Number OR | 5.1 ± 3.3 | 5.1 ± 3.4 | 5.2 ± 3.0 | NS |
Time between OR | 5.3 ± 1.7 | 5.3 ± 1.7 | 5.1 ± 2.0 | NS |
LOS ICU, d | 37.8 ± 27.1 | 36.1 ± 24.0 | 38.8 ± 29.2 | NS |
LOS/TBSA | 0.7 ± 0.8 | 0.6 ± 0.3 | 1.1 ± 2.2 | <.05 |
Died, No. (%) | 38 (10.2) | 23 (7.2) | 15 (29.4) | <.001 |
Max DENVER2 | 3.7 ± 1.8 | 3.5 ± 1.5 | 5.1 ± 2.4 | <.05 |
MOF, No. (%) | 81 (21.8) | 55 (17.1) | 26 (51.0) | <.05 |
Sepsis, No. (%) | 54 (14.5) | 34 (10.6) | 20 (39.2) | <.001 |
No. infections | 2.7 ± 2.5 | 2.6 ± 2.4 | 3.1 ± 3.1 | NS |
Data presented as mean ± SD unless otherwise indicated. Patients with low RBP levels showed a significantly lower incidence of clinical complications (MOF, sepsis) and mortality.
ICU, intensive care unit; LOS, length of stay; MOF, multiorgan failure; NS, not significant; OR, operations; RBP, retinol binding protein; TBSA, total body surface area.